Similar articles for PMID: 31684111

Year	Number of Results
2015	1
2017	6
2018	6
2019	27
2020	23
2021	16
2022	14
2023	6
2024	0

1

The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors.

Meyers DE, Stukalin I, Vallerand IA, Lewinson RT, Suo A, Dean M, North S, Pabani A, Cheng T, Heng DYC, Bebb DG, Morris DG. Meyers DE, et al. Cancers (Basel). 2019 Nov 2;11(11):1713. doi: 10.3390/cancers11111713. Cancers (Basel). 2019. PMID: 31684111 Free PMC article.

2

Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer.

Mezquita L, Auclin E, Ferrara R, Charrier M, Remon J, Planchard D, Ponce S, Ares LP, Leroy L, Audigier-Valette C, Felip E, Zerón-Medina J, Garrido P, Brosseau S, Zalcman G, Mazieres J, Caramela C, Lahmar J, Adam J, Chaput N, Soria JC, Besse B. Mezquita L, et al. JAMA Oncol. 2018 Mar 1;4(3):351-357. doi: 10.1001/jamaoncol.2017.4771. JAMA Oncol. 2018. PMID: 29327044 Free PMC article.

3

Association of the pretreatment lung immune prognostic index with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors.

Hou B, Wang P, Liu T, Chen S, Li T, Zhang S, Tao H, Li X, Hu Y. Hou B, et al. Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101748. doi: 10.1016/j.clinre.2021.101748. Epub 2021 Jun 25. Clin Res Hepatol Gastroenterol. 2021. PMID: 34182184

4

Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI Score.

Pierro M, Baldini C, Auclin E, Vincent H, Varga A, Martin Romano P, Vuagnat P, Besse B, Planchard D, Hollebecque A, Champiat S, Marabelle A, Michot JM, Massard C, Mezquita L. Pierro M, et al. Cancers (Basel). 2022 Oct 17;14(20):5078. doi: 10.3390/cancers14205078. Cancers (Basel). 2022. PMID: 36291861 Free PMC article.

5

Pretreatment Lung Immune Prognostic Index Is a Prognostic Marker of Chemotherapy and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.

Minami S, Ihara S, Komuta K. Minami S, et al. World J Oncol. 2019 Feb;10(1):35-45. doi: 10.14740/wjon1179. Epub 2019 Feb 26. World J Oncol. 2019. PMID: 30834050 Free PMC article.

6

Evaluation of the Lung Immune Prognostic Index for Prediction of Survival and Response in Patients Treated With Atezolizumab for NSCLC: Pooled Analysis of Clinical Trials.

Sorich MJ, Rowland A, Karapetis CS, Hopkins AM. Sorich MJ, et al. J Thorac Oncol. 2019 Aug;14(8):1440-1446. doi: 10.1016/j.jtho.2019.04.006. Epub 2019 Apr 15. J Thorac Oncol. 2019. PMID: 30999110 Free article.

7

Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer.

Wang W, Huang Z, Yu Z, Zhuang W, Zheng W, Cai Z, Shi L, Yu X, Lou G, Hong W, Zhang Y, Chen M, Song Z. Wang W, et al. Front Oncol. 2020 Oct 9;10:572853. doi: 10.3389/fonc.2020.572853. eCollection 2020. Front Oncol. 2020. PMID: 33163403 Free PMC article.

8

Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial.

Hopkins AM, Kichenadasse G, Abuhelwa AY, McKinnon RA, Rowland A, Sorich MJ. Hopkins AM, et al. Cancers (Basel). 2021 Mar 9;13(5):1176. doi: 10.3390/cancers13051176. Cancers (Basel). 2021. PMID: 33803256 Free PMC article.

9

Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non-Small Cell Lung Cancer.

Kazandjian D, Gong Y, Keegan P, Pazdur R, Blumenthal GM. Kazandjian D, et al. JAMA Oncol. 2019 Oct 1;5(10):1481-1485. doi: 10.1001/jamaoncol.2019.1747. JAMA Oncol. 2019. PMID: 31343662 Free PMC article.

10

Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma.

Parent P, Auclin E, Patrikidou A, Mezquita L, Martínez Chanzá N, Dumont C, Rodriguez-Vida A, Llacer C, Lozano R, Ratta R, Merseburger AS, Sternberg CN, Baciarello G, Colomba E, Fuerea A, Besse B, Loriot Y, Lavaud P. Parent P, et al. Cancers (Basel). 2023 Feb 7;15(4):1066. doi: 10.3390/cancers15041066. Cancers (Basel). 2023. PMID: 36831409 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year